273 related articles for article (PubMed ID: 28653240)
1. ImmunoPET Imaging of α
White JB; Hu LY; Boucher DL; Sutcliffe JL
Mol Imaging Biol; 2018 Feb; 20(1):103-113. PubMed ID: 28653240
[TBL] [Abstract][Full Text] [Related]
2. Development and characterization of an αvβ6-specific diabody and a disulfide-stabilized αvβ6-specific cys-diabody.
White JB; Boucher DL; Zettlitz KA; Wu AM; Sutcliffe JL
Nucl Med Biol; 2015 Dec; 42(12):945-57. PubMed ID: 26341848
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Copper-64-Labeled α
Ganguly T; Bauer N; Davis RA; Hausner SH; Tang SY; Sutcliffe JL
Mol Pharm; 2021 Dec; 18(12):4437-4447. PubMed ID: 34783573
[TBL] [Abstract][Full Text] [Related]
4. The Effects of an Albumin Binding Moiety on the Targeting and Pharmacokinetics of an Integrin α
Hausner SH; Bauer N; Davis RA; Ganguly T; Tang SYC; Sutcliffe JL
Mol Imaging Biol; 2020 Dec; 22(6):1543-1552. PubMed ID: 32383076
[TBL] [Abstract][Full Text] [Related]
5. Site-specific conjugation of monodispersed DOTA-PEGn to a thiolated diabody reveals the effect of increasing peg size on kidney clearance and tumor uptake with improved 64-copper PET imaging.
Li L; Crow D; Turatti F; Bading JR; Anderson AL; Poku E; Yazaki PJ; Carmichael J; Leong D; Wheatcroft D; Raubitschek AA; Hudson PJ; Colcher D; Shively JE
Bioconjug Chem; 2011 Apr; 22(4):709-16. PubMed ID: 21395337
[TBL] [Abstract][Full Text] [Related]
6. The Effect of Bi-Terminal PEGylation of an Integrin αvβ₆-Targeted ¹⁸F Peptide on Pharmacokinetics and Tumor Uptake.
Hausner SH; Bauer N; Hu LY; Knight LM; Sutcliffe JL
J Nucl Med; 2015 May; 56(5):784-90. PubMed ID: 25814519
[TBL] [Abstract][Full Text] [Related]
7. PET Imaging of HER2-Positive Tumors with Cu-64-Labeled Affibody Molecules.
Qi S; Hoppmann S; Xu Y; Cheng Z
Mol Imaging Biol; 2019 Oct; 21(5):907-916. PubMed ID: 30617730
[TBL] [Abstract][Full Text] [Related]
8. Use of a peptide derived from foot-and-mouth disease virus for the noninvasive imaging of human cancer: generation and evaluation of 4-[18F]fluorobenzoyl A20FMDV2 for in vivo imaging of integrin alphavbeta6 expression with positron emission tomography.
Hausner SH; DiCara D; Marik J; Marshall JF; Sutcliffe JL
Cancer Res; 2007 Aug; 67(16):7833-40. PubMed ID: 17699789
[TBL] [Abstract][Full Text] [Related]
9. ImmunoPET Imaging of CD146 in Murine Models of Intrapulmonary Metastasis of Non-Small Cell Lung Cancer.
England CG; Jiang D; Hernandez R; Sun H; Valdovinos HF; Ehlerding EB; Engle JW; Yang Y; Huang P; Cai W
Mol Pharm; 2017 Oct; 14(10):3239-3247. PubMed ID: 28825843
[TBL] [Abstract][Full Text] [Related]
10. Reduction of kidney uptake in radiometal labeled peptide linkers conjugated to recombinant antibody fragments. Site-specific conjugation of DOTA-peptides to a Cys-diabody.
Li L; Olafsen T; Anderson AL; Wu A; Raubitschek AA; Shively JE
Bioconjug Chem; 2002; 13(5):985-95. PubMed ID: 12236780
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of [64Cu]Cu-DOTA and [64Cu]Cu-CB-TE2A chelates for targeted positron emission tomography with an alphavbeta6-specific peptide.
Hausner SH; Kukis DL; Gagnon MK; Stanecki CE; Ferdani R; Marshall JF; Anderson CJ; Sutcliffe JL
Mol Imaging; 2009; 8(2):111-21. PubMed ID: 19397856
[TBL] [Abstract][Full Text] [Related]
12. ImmunoPET for assessing the differential uptake of a CD146-specific monoclonal antibody in lung cancer.
Sun H; England CG; Hernandez R; Graves SA; Majewski RL; Kamkaew A; Jiang D; Barnhart TE; Yang Y; Cai W
Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2169-2179. PubMed ID: 27342417
[TBL] [Abstract][Full Text] [Related]
13. 18F-fluorobenzoate-labeled cystine knot peptides for PET imaging of integrin αvβ6.
Hackel BJ; Kimura RH; Miao Z; Liu H; Sathirachinda A; Cheng Z; Chin FT; Gambhir SS
J Nucl Med; 2013 Jul; 54(7):1101-5. PubMed ID: 23670900
[TBL] [Abstract][Full Text] [Related]
14. PET imaging of insulin-like growth factor type 1 receptor expression with a 64Cu-labeled Affibody molecule.
Su X; Cheng K; Liu Y; Hu X; Meng S; Cheng Z
Amino Acids; 2015 Jul; 47(7):1409-19. PubMed ID: 25854877
[TBL] [Abstract][Full Text] [Related]
15. Generation and characterization of a diabody targeting the αvβ6 integrin.
Kogelberg H; Miranda E; Burnet J; Ellison D; Tolner B; Foster J; Picón C; Thomas GJ; Meyer T; Marshall JF; Mather SJ; Chester K
PLoS One; 2013; 8(9):e73260. PubMed ID: 24023846
[TBL] [Abstract][Full Text] [Related]
16. Characterization and evaluation of (64)Cu-labeled A20FMDV2 conjugates for imaging the integrin αvβ 6.
Hu LY; Bauer N; Knight LM; Li Z; Liu S; Anderson CJ; Conti PS; Sutcliffe JL
Mol Imaging Biol; 2014 Aug; 16(4):567-77. PubMed ID: 24448825
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, Positron Emission Tomography Imaging, and Therapy of Diabody Targeted Drug Lipid Nanoparticles in a Prostate Cancer Murine Model.
Wong P; Li L; Chea J; Delgado MK; Poku E; Szpikowska B; Bowles N; Minnix M; Colcher D; Wong JYC; Shively JE; Yazaki PJ
Cancer Biother Radiopharm; 2017 Sep; 32(7):247-257. PubMed ID: 28910151
[TBL] [Abstract][Full Text] [Related]
18. In Vivo PET Imaging of the Cancer Integrin αvβ6 Using
Notni J; Reich D; Maltsev OV; Kapp TG; Steiger K; Hoffmann F; Esposito I; Weichert W; Kessler H; Wester HJ
J Nucl Med; 2017 Apr; 58(4):671-677. PubMed ID: 27980050
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Cu-64 and Ga-68 Radiolabeled Glucagon-Like Peptide-1 Receptor Agonists as PET Tracers for Pancreatic β cell Imaging.
Bandara N; Zheleznyak A; Cherukuri K; Griffith DA; Limberakis C; Tess DA; Jianqing C; Waterhouse R; Lapi SE
Mol Imaging Biol; 2016 Feb; 18(1):90-8. PubMed ID: 25987465
[TBL] [Abstract][Full Text] [Related]
20. ImmunoPET and Near-Infrared Fluorescence Imaging of Pancreatic Cancer with a Dual-Labeled Bispecific Antibody Fragment.
Luo H; England CG; Goel S; Graves SA; Ai F; Liu B; Theuer CP; Wong HC; Nickles RJ; Cai W
Mol Pharm; 2017 May; 14(5):1646-1655. PubMed ID: 28292180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
